New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
08:21 EDTNWBONorthwest Biotherapeutics' DCVax for tumors shows positive Phase I/II results
Northwest Biotherapeutics announced that, in the ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors, all 9 out of 9 patients who have received 4 of the 6 planned injections are showing tumor cell death, tumor shrinkage, substantial immune cell accumulation in their tumors and/or stabilization of their advanced cancer. In addition, in 3 of these 9 patients, biopsies now show no live tumor cells in the injected tumor. The company plans to report more details when the patients are further along in the treatment regimen.
News For NWBO From The Last 14 Days
Check below for free stories on NWBO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 19, 2014
10:42 EDTNWBOOptions with decreasing implied volatility
Subscribe for More Information
August 13, 2014
09:32 EDTNWBONorthwest Biotherapeutics says claims by Feuerstein about DCVax trial 'false'
Subscribe for More Information
09:30 EDTNWBONorthwest Biotherapeutics says claims by Feuerstein about DCVax trial 'false'
Subscribe for More Information
August 12, 2014
11:27 EDTNWBONorthwest Bio trial changes 'hint at failure,' TheStreet's Feuerstein says
Subscribe for More Information
August 11, 2014
08:16 EDTNWBONorthwest Biotherapeutics obtains approvals for enhancements of DCVAX trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use